Carrier-Free Curcumin Nanoparticle for EGFR Positive Cancer Therapy

Description:

Reference #: 01472

The University of South Carolina is offering licensing opportunities for Carrier-free curcumin nanoparticle for EGFR positive cancer therapy

Background: 

Due to their small size and large surface area, drug nanoparticles show great promise in improving drug delivery in patients.

Invention Description:

Most nanoparticle based drug delivery systems are composed of a carrier and a payload. However, due to the low drug loading content, premature drug release, non-standardized or uniform carrier structure, and difficulty in predicating the fate of the carrier, only a few nanomedicines have been approved by FDA.

Potential Applications:

Cancer treatment

Advantages and Benefits:

lower toxicity, high potency, better survival rate

Patent Information:
Title App Type Country Serial No. Patent No. File Date Issued Date Expire Date Patent Status
Carrier-Free Curcumin Nanoparticle for EGFR Positive Cancer Therapy Utility United States 17/213,750 11,904,022 3/26/2021 2/20/2024   Issued
For Information, Contact:
Lacie Cottrill
Technology Associate
University of South Carolina
lacie@mailbox.sc.edu
Inventors:
Peisheng Xu
Keywords:
cancer
carrier-free
curcumin
EGFR receptor
erlotinib
nanoparticle
Nanotechnology
© 2024. All Rights Reserved. Powered by Inteum